Visual Abstract

Higher HbA1c is associated with worse average lipid trajectory in T1D. It is unknown if there is heterogeneity in this association. Thus we assessed the 30-yr association between HbA1c and both Non-HDLc and HDLc in a T1D cohort, examining varying longitudinal patterns in association with mortality. Data are from the Pittsburgh Epidemiology of Diabetes Complications study (n=658, 51% male, baseline mean age 27 yrs, T1D duration 19 yrs). Longitudinal associations between HbA1c and Non-HDLc were assessed in mixed models. The same analysis was performed for HDLc separately by sex. Group based multi-trajectory models identified simultaneous trajectories of HbA1c and each lipid. Over 30 yr each 1% higher HbA1c was associated with 6.6±0.4 mg/dl greater Non-HDLc (p<0.001). There was no association between HbA1c and HDLc (men: p=0.72, women: p=0.76). Five HbA1c - Non-HDLc combined groups were identified (Figure 1). Group 1 had the best HbA1c and Non-HDLc trajectories. Group 2 had an unexpected combination of high HbA1c but normal Non-HDLc and was characterized by better baseline systolic blood pressure (p=0.03) and estimated glomerular filtration rate (p<0.001) compared to Group 1. Group 2 had moderately elevated total and cardiovascular (CVD) mortality, but not end-stage renal disease (ESRD) mortality. These results suggest there is a subgroup with T1D who, despite high HbA1c, is at relatively low renal risk, perhaps related to good Non-HDLc.


R. G. Miller: None. T. J. Orchard: None. T. Costacou: None.


American Diabetes Association (1-19-JDF-109 to R.G.M.); National Institute of Diabetes and Digestive and Kidney Diseases (R01DK034818)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at